Identification and management of glaucoma

Abstract

Glaucoma is the leading cause of irreversible blindness and the aim of all glaucoma treatments is to lower intraocular pressure (IOP), the only modifiable risk factor. This article summarises the identification and management of open‐angle and closed‐angle glaucoma, including medical, laser and surgical treatment options.

Smart molecules in ophthalmology: Hydrogels as responsive systems for ophthalmic applications

“…[49] Presently, eye drops constitute the most common form of glaucoma management. [50] However, penetration into the deeper tissues of the eyes remains a challenge with this method. [51] Moreover, drug loss through nasolacrimal drainage is a frequent issue with conventional formulations, thereby resulting in low ocular bioavailability and high systemic exposure.…”

“…In most cases, a dysfunction in the ocular drainage system leads to a buildup of fluid, ultimately leading to an excessive increase in intraocular pressure (IOP) [49] . Presently, eye drops constitute the most common form of glaucoma management [50] . However, penetration into the deeper tissues of the eyes remains a challenge with this method [51] .…”

Inhibidores RHO quinasa en el tratamiento del glaucoma de ángulo abierto.

“…Es ocasionado por disímiles causas, como: inflamación ocular, hipertensión venosa epiesclerótica, tumores oculares, congénito (22). Previos a la crisis, pueden existir síntomas prodrómicos de episodios de visión borrosa o halos de colores alrededor de las luces, en ocasiones el paciente no lo nota y vuelven espontáneamente a la normalidad.…”

“…La crisis como tal, comienza con un dolor agudo e intenso, una elevación sustancial de la PIO que afecta a las neuronas de la córnea provocando un dolor que se expande hasta las sienes, región occipital y maxilares. Este dolor va acompañado de náuseas, vómitos, visión borrosa, irritación ocular y edema corneal (22).…”